Investments are made in Dana-Farber startup companies that were created either with Dana-Farber intellectual property or capitalize on Dana-Farber's expertise.
We focus on therapeutics as well as novel diagnostics, tools, digital health, and services companies.
We invest across multiple therapeutic areas with a strong presence in oncology and immunology.
Strategy
We invest in companies advancing innovative therapies and products that have the potential to transform patient lives.
We invest alongside other venture capital groups across all financing rounds, with an emphasis on Seed and Series A investments.
Investment decisions are guided by our advisory group comprised of leading investors and industry experts committed to furthering Dana-Farber’s mission.
Differentiation
We catalyze early company formation and growth by serving as a resource for early stage VCs, companies, and management teams.
Our team supports company builds and takes active operational roles.
We are a resource for Dana-Farber investigators. We meet and offer feedback and assistance with strategies around fundraising, commercialization, and translation of research regardless of the stage of development.